Covance Executive Leadership

At Covance, we understand the complexity of the drug development process and the challenges you face. As your proactive partner, we’ll identify hurdles and address strategic approaches to evolve with your project. Together, we can achieve your milestones and help set you up for success. 

Our Executive Leadership team is committed to delivering innovative solutions that transform scientific possibilities into realities. Having helped develop 49 of the top 50 best-selling drugs in the market today, we have proven ability to help deliver Solutions Made Real®.

John Ratliff - CEO, Covance Drug Development

John Ratliff
Chief Executive Officer

Steven Anderson, PhD - Chief Scientific Officer (CSO)

Steven Anderson
Chief Scientific Officer

Dr. Dimitris K. Agrafiotis, Ph.D., FRSC - Vice President and Chief Data Officer, Covance

Dimitris Agrafiotis
Chief Data Officer

Honggang Bi - General Manager, China

Honggang Bi
General Manager, China

Chris Gegelys - General Counsel

Chris Gegelys
General Counsel

John Gransee, M.B.A., C.P.A. - Chief Financial Officer, Covance

John Gransee
Chief Financial Officer

Jonathan Koch - Group President, R&D Laboratories

Jonathan Koch
Group President, R&D Laboratories

Vicki Neddenriep - Vice President, Global HR Partnering

Vicki Neddenriep
Global HR Partnering

Ken Somberg - Chief Medical Officer

Ken Somberg
Chief Medical Officer

Jonathan Zung, Ph.D. - Group President, Clinical Development & Commercialization Services

Jonathan Zung
Group President, Clinical Development & Commercialization Services